Home/Filings/4/A/0001104659-23-062821
4/A//SEC Filing

Chaturvedi Pravin R 4/A

Accession 0001104659-23-062821

CIK 0001585608other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 8:44 PM ET

Size

7.9 KB

Accession

0001104659-23-062821

Insider Transaction Report

Form 4/AAmended
Period: 2022-04-05
Chaturvedi Pravin R
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-04-05+10,00010,000 total
  • Award

    Restricted stock units

    2022-04-05+10,00020,000 total
    Common Stock (10,000 underlying)
Footnotes (3)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]On September 8, 2021, the issuer effected a 3-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "Reverse Stock Split). Upon effectiveness of the Reverse Stock Split, every 3 shares of voting common stock was automatically converted into one share of voting common stock.
  • [F3]On April 6, 2022, the reporting person filed a Form 4 that erroneously indicated that 3,333 restricted stock units had vested on April 5, 2022 and that the reporting person beneficially owned 6,666 restricted stock units following such vesting. In fact, 10,000 restricted stock units had vested on such date and the reporting person beneficially owned 20,000 restricted stock units following such vesting.

Issuer

Jaguar Health, Inc.

CIK 0001585608

Entity typeother

Related Parties

1
  • filerCIK 0001916935

Filing Metadata

Form type
4/A
Filed
May 18, 8:00 PM ET
Accepted
May 19, 8:44 PM ET
Size
7.9 KB